Antioxidant activity, α-glucosidase inhibition and phytochemical profiling of
Antidiabetic
Antioxidant
Diabetes mellitus
Hyophorbe lagenicaulis
UHPLC-Q-TOF-MS/MS
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
09
2018
accepted:
25
04
2019
entrez:
2
7
2019
pubmed:
2
7
2019
medline:
2
7
2019
Statut:
epublish
Résumé
Diabetes mellitus type II (DMT-2) is a widely spread metabolic disorder both in developed and developing countries. The role of oxidative stress is well established in DMT-2 pathogenesis. The synthetic drugs for DMT-2 are associated with serious side complications. Antioxidant and α-glucosidase inhibitory actions of phytochemicals from various plant species are considered as an alternative to synthetic drugs for DMT-2 management. The present study aimed to evaluate the antioxidant activity, α-glucosidase inhibitory potential and phytochemical profiling of The total phenolic and flavonoid contents, in vitro antioxidant activity (α, α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging and phosphomolybdenum method) and α-glucosidase inhibition of ultrasonicated hydroethanolic Findings leaped 60% ethanolic extract as rich fraction regarding total phenolic and flavonoid contents. The 60% ethanolic fraction was a promising source of natural antioxidants and α-glucosidase inhibitory agents as indicated by anti-radical and enzyme inibitory activities. Kaempferol, rutin, hesperetin 5-O-glucoside, kaempferol-coumaroyl-glucoside, luteolin 3-glucoside, Isorhamnetin-3-O-rutinoside, trimethoxyflavone derivatives and citric acid were identified by UHPLC-Q-TOF-MS/MS. These compounds were believed to be responsible for the strong antioxidant and enzyme inhibitory activity of plant extracts. The extensive metabolite profiling of
Sections du résumé
BACKGROUND
BACKGROUND
Diabetes mellitus type II (DMT-2) is a widely spread metabolic disorder both in developed and developing countries. The role of oxidative stress is well established in DMT-2 pathogenesis. The synthetic drugs for DMT-2 are associated with serious side complications. Antioxidant and α-glucosidase inhibitory actions of phytochemicals from various plant species are considered as an alternative to synthetic drugs for DMT-2 management. The present study aimed to evaluate the antioxidant activity, α-glucosidase inhibitory potential and phytochemical profiling of
METHODS
METHODS
The total phenolic and flavonoid contents, in vitro antioxidant activity (α, α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging and phosphomolybdenum method) and α-glucosidase inhibition of ultrasonicated hydroethanolic
RESULTS AND DISCUSSION
CONCLUSIONS
Findings leaped 60% ethanolic extract as rich fraction regarding total phenolic and flavonoid contents. The 60% ethanolic fraction was a promising source of natural antioxidants and α-glucosidase inhibitory agents as indicated by anti-radical and enzyme inibitory activities. Kaempferol, rutin, hesperetin 5-O-glucoside, kaempferol-coumaroyl-glucoside, luteolin 3-glucoside, Isorhamnetin-3-O-rutinoside, trimethoxyflavone derivatives and citric acid were identified by UHPLC-Q-TOF-MS/MS. These compounds were believed to be responsible for the strong antioxidant and enzyme inhibitory activity of plant extracts. The extensive metabolite profiling of
Identifiants
pubmed: 31259094
doi: 10.7717/peerj.7022
pii: 7022
pmc: PMC6589327
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7022Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Anal Biochem. 1999 May 1;269(2):337-41
pubmed: 10222007
Biosci Biotechnol Biochem. 2000 Nov;64(11):2458-61
pubmed: 11193416
Chem Biol Interact. 2007 Aug 15;169(1):15-24
pubmed: 17537413
Vasc Health Risk Manag. 2008;4(6):1189-95
pubmed: 19337532
Diabetes Care. 2009 Nov;32 Suppl 2:S232-6
pubmed: 19875557
Food Chem Toxicol. 2010 Oct;48(10):2638-41
pubmed: 20600531
Nutrition. 2011 Nov-Dec;27(11-12):1161-7
pubmed: 21684120
Phytochemistry. 2013 Dec;96:443-8
pubmed: 24120299
Biomed Res Int. 2013;2013:527570
pubmed: 24455701
Iran Biomed J. 2014;18(2):82-7
pubmed: 24518548
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
J Food Sci Technol. 2014 Sep;51(9):2070-7
pubmed: 25190865
Molecules. 2014 Nov 19;19(11):19180-208
pubmed: 25415479
Evid Based Complement Alternat Med. 2015;2015:587383
pubmed: 25767553
Mini Rev Med Chem. 2015;15(7):524-8
pubmed: 25934979
Curr Med Res Opin. 2016;32(2):207-18
pubmed: 26473650
Evid Based Complement Alternat Med. 2015;2015:469762
pubmed: 26557860
Diabetes Care. 2016 Feb;39(2):179-86
pubmed: 26798148
Asian Pac J Trop Med. 2016 Sep;9(9):825-831
pubmed: 27633293
Saudi Pharm J. 2016 Sep;24(5):547-553
pubmed: 27752226
Front Endocrinol (Lausanne). 2017 Jan 24;8:6
pubmed: 28167928
Pharm Biol. 2017 Dec;55(1):1483-1488
pubmed: 28367665
Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):65-71
pubmed: 28539866
PeerJ. 2018 Feb 20;6:e4389
pubmed: 29479498
BMC Complement Altern Med. 2018 Mar 9;18(1):82
pubmed: 29523107
Food Technol Biotechnol. 2017 Dec;55(4):519-530
pubmed: 29540986
Pak J Pharm Sci. 2018 Mar;31(2(Suppl.)):637-642
pubmed: 29625935
Nutrients. 2018 Jul 25;10(8):null
pubmed: 30044398
PeerJ. 2018 Aug 3;6:e5331
pubmed: 30083463